Urgent New Alert: About Coming Once-in-a-generation Wealth Shift
Here is the latest financial fact sheet of Dishman Pharma. For more details, see the Dishman Pharma quarterly results and Dishman Pharma share price and chart. For a sector overview, read our pharmaceuticals sector report.
% ch | % | 2.9 |
No. of shares | m | 161.39 |
% ch week | % | 3.5 |
% ch 1-mth | % | -2.4 |
% ch 12-mth | % | 96.4 |
52 week H/L | Rs | 346.3/127.6 |
No. of Mths Year Ending |
12 Mar-12* |
12 Mar-13* |
12 Mar-14* |
12 Mar-15* |
12 Mar-16* |
5-Yr Chart Click to enlarge
|
---|
DISHMAN PHARMA EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 107 | 122 | 107 | 183 | 374 | |
Low | Rs | 35 | 42 | 39 | 83 | 129 | |
Sales per share (Unadj.) | Rs | 139.3 | 157.7 | 171.7 | 196.9 | 197.8 | |
Earnings per share (Unadj.) | Rs | 7.0 | 12.4 | 13.5 | 14.8 | 21.2 | |
Diluted earnings per share | Rs | 3.5 | 6.2 | 6.8 | 7.4 | 10.6 | |
Cash flow per share (Unadj.) | Rs | 16.5 | 22.8 | 27.0 | 33.5 | 34.7 | |
Dividends per share (Unadj.) | Rs | 1.20 | 1.20 | 1.20 | 2.00 | 2.00 | |
Adj. dividends per share | Rs | 0.60 | 0.60 | 0.60 | 1.00 | 1.00 | |
Dividend yield (eoy) | % | 1.7 | 1.5 | 1.6 | 1.5 | 0.8 | |
Book value per share (Unadj.) | Rs | 115.3 | 128.2 | 146.4 | 153.4 | 179.9 | |
Adj. book value per share | Rs | 57.7 | 64.1 | 73.2 | 76.7 | 89.9 | |
Shares outstanding (eoy) | m | 80.69 | 80.69 | 80.69 | 80.69 | 80.69 | |
Bonus/Rights/Conversions | - | - | - | - | - | ||
Price / Sales ratio | x | 0.5 | 0.5 | 0.4 | 0.7 | 1.3 | |
Avg P/E ratio | x | 10.1 | 6.6 | 5.4 | 8.9 | 11.9 | |
P/CF ratio (eoy) | x | 4.3 | 3.6 | 2.7 | 4.0 | 7.2 | |
Price / Book Value ratio | x | 0.6 | 0.6 | 0.5 | 0.9 | 1.4 | |
Dividend payout | % | 17.1 | 9.7 | 8.9 | 13.5 | 9.4 | |
Avg Mkt Cap | Rs m | 5,729 | 6,617 | 5,902 | 10,691 | 20,306 | |
No. of employees | `000 | 1.0 | 1.1 | 0.9 | 0.9 | 0.8 | |
Total wages/salary | Rs m | 2,941 | 3,509 | 4,123 | 4,232 | 5,355 | |
Avg. sales/employee | Rs Th | 11,541.3 | 12,059.0 | 14,848.0 | 18,430.9 | 19,252.7 | |
Avg. wages/employee | Rs Th | 3,019.6 | 3,326.2 | 4,419.4 | 4,909.6 | 6,459.5 | |
Avg. net profit/employee | Rs Th | 582.8 | 950.6 | 1,171.2 | 1,389.9 | 2,064.1 |
DISHMAN PHARMA INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 11,241 | 12,722 | 13,853 | 15,887 | 15,961 | |
Other income | Rs m | 129 | 178 | 249 | 869 | 265 | |
Total revenues | Rs m | 11,370 | 12,900 | 14,102 | 16,757 | 16,226 | |
Gross profit | Rs m | 2,245 | 2,901 | 3,321 | 3,128 | 4,103 | |
Depreciation | Rs m | 765 | 838 | 1,086 | 1,507 | 1,091 | |
Interest | Rs m | 729 | 788 | 921 | 897 | 944 | |
Profit before tax | Rs m | 879 | 1,453 | 1,564 | 1,593 | 2,334 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 1 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 312 | 450 | 471 | 394 | 624 | |
Profit after tax | Rs m | 568 | 1,003 | 1,093 | 1,198 | 1,711 | |
Gross profit margin | % | 20.0 | 22.8 | 24.0 | 19.7 | 25.7 | |
Effective tax rate | % | 35.4 | 31.0 | 30.1 | 24.8 | 26.7 | |
Net profit margin | % | 5.0 | 7.9 | 7.9 | 7.5 | 10.7 |
DISHMAN PHARMA BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 6,239 | 6,733 | 8,245 | 10,135 | 11,018 | |
Current liabilities | Rs m | 6,547 | 7,127 | 9,028 | 11,048 | 9,517 | |
Net working cap to sales | % | -2.7 | -3.1 | -5.7 | -5.7 | 9.4 | |
Current ratio | x | 1.0 | 0.9 | 0.9 | 0.9 | 1.2 | |
Inventory Days | Days | 87 | 97 | 112 | 103 | 110 | |
Debtors Days | Days | 61 | 21 | 38 | 50 | 35 | |
Net fixed assets | Rs m | 14,391 | 14,579 | 15,717 | 15,827 | 16,304 | |
Share capital | Rs m | 161 | 161 | 161 | 161 | 161 | |
"Free" reserves | Rs m | 8,225 | 9,051 | 10,031 | 11,167 | 12,907 | |
Net worth | Rs m | 9,307 | 10,345 | 11,813 | 12,378 | 14,516 | |
Long term debt | Rs m | 5,121 | 4,336 | 4,121 | 3,302 | 4,189 | |
Total assets | Rs m | 22,490 | 22,911 | 26,277 | 28,089 | 29,805 | |
Interest coverage | x | 2.2 | 2.8 | 2.7 | 2.8 | 3.5 | |
Debt to equity ratio | x | 0.6 | 0.4 | 0.3 | 0.3 | 0.3 | |
Sales to assets ratio | x | 0.5 | 0.6 | 0.5 | 0.6 | 0.5 | |
Return on assets | % | 5.8 | 7.8 | 7.7 | 7.5 | 8.9 | |
Return on equity | % | 6.1 | 9.7 | 9.3 | 9.7 | 11.8 | |
Return on capital | % | 11.1 | 15.3 | 15.6 | 15.9 | 17.5 | |
Exports to sales | % | 30.3 | 28.3 | 27.8 | 22.6 | 24.8 | |
Imports to sales | % | 7.2 | 4.7 | 6.3 | 5.6 | 3.7 | |
Exports (fob) | Rs m | 3,404 | 3,595 | 3,855 | 3,598 | 3,956 | |
Imports (cif) | Rs m | 806 | 599 | 869 | 891 | 596 | |
Fx inflow | Rs m | 3,974 | 4,210 | 3,966 | 4,576 | 4,952 | |
Fx outflow | Rs m | 905 | 695 | 954 | 974 | 697 | |
Net fx | Rs m | 3,069 | 3,515 | 3,011 | 3,601 | 4,255 |
DISHMAN PHARMA CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 1,536 | 1,651 | 3,445 | 2,937 | 2,786 | |
From Investments | Rs m | -1,040 | -1,173 | -2,568 | -1,581 | -1,529 | |
From Financial Activity | Rs m | -680 | -502 | -741 | -1,420 | -941 | |
Net Cashflow | Rs m | -185 | -23 | 136 | -64 | 316 |
Share Holding
|
Company Information
|
CHM: Janmejay R. Vyas (MD) | COMP SEC: Tushar D. Shah | YEAR OF INC: 1983 | BSE CODE: 532526 | FV (Rs): 2 | DIV YIELD (%): 0.3 |
More Pharmaceuticals Company Fact Sheets: GLENMARK PHARMA ELDER PHARMA ALKEM LABORATORIES J.B.CHEMICALS FDC
Compare DISHMAN PHARMA With: GLENMARK PHARMA ELDER PHARMA ALKEM LABORATORIES J.B.CHEMICALS FDC
Compare DISHMAN PHARMA With: ACTAVIS (US) ADCOCK INGRAM (S. Africa) MYLAN (US) TEVA PHARMA (Israel)
Indian share markets witnessed volatile trading activity throughout the day today and ended marginally lower.
In this video, I'll tell you why I am recommending caution in the market at this time.
A tiny chemical company, started in the Licence Raj era, is a great example of a new wealth creating opportunity.
In this video I'll show you exactly how I go about picking stocks for trading.
100 baggers of the last decade share this common trait. Here's how to use it to nail future multibaggers.
More